| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2017-07-18 | TomTec Imaging Systems (Germany) | Philips (The Netherlands) | undisclosed | Technology - Services |
| 2017-07-17 | Merus Labs International (Canada) | Norgine (The Netherlands) | C$342 million | |
| 2017-07-10 | Amatsigroup (France) | Eurofins Scientific (Luxembourg) | € 130 million | Technology - Services |
| 2017-07-06 | Capsugel (USA - NJ) | Lonza (Switzerland) | $ 5.5 billion | Technology - Services - Bioproduction - Manufacturing |
| 2017-06-30 | mySugr (Austria) | Roche (Switzerland) | undisclosed | diabetes |
| 2017-06-28 | True North Therapeutics (USA - CA) | Bioverativ (USA - MA) | up to $825 million | Genetic diseases - Rare diseases - Hematological disease |
| 2017-06-26 | Innova Biosciences (UK) | Sygnis (Germany) | ||
| 2017-06-26 | Genoma Group (Italy) | Eurofins Scientific (Luxembourg) | undisclosed | |
| 2017-06-16 | Actelion (Switzerland) | Johnson&Johnson (J&J) (USA - NJ) | $30 billion | Rare diseases |
| 2017-06-13 | Alphora Research (Canada) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-05-30 | Pharmacell (The Netherlands) | Lonza (Switzerland) | undisclosed | Technology - Services - Bioproduction - Manufacturing |
| 2017-05-16 | HansaBioMed Life Sciences (Estonia) | Lonza (Switzerland) | undisclosed | Technology - Services |
| 2017-05-09 | iLab, Biosphere and two specialty clinical testing laboratories (France) | Eurofins Scientific (Luxembourg) | diagnostic | |
| 2017-05-04 | MVZ für Laboratoriumsmedizin am Hygiene-Institut GmbH (Hygel) (Germany) | Eurofins Scientific (Luxembourg) | diagnostic | |
| 2017-05-04 | Hygel (Germany) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-05-03 | MiNA Therapeutics (UK) | Sosei (Japan) | £ 175 million | Cancer - Oncology |
| 2017-04-11 | Asymptote (UK) | GE Healthcare (USA - WI) | undisclosed | Technology - Services |
| 2017-04-03 | assets and relevant business related to the CELLSEARCH® Circulating Tumor Cell System from Janssen Diagnostics (USA - PA) | Menarini-Silicon Biosystems, a Menarini group company (Italy) | undisclosed | Cancer - Oncology - Diagnostic |
| 2017-03-30 | Symetis (Switzerland) | Boston Scientific (USA - MA) | $435 million | Medical devices Cardiovascular diseases |
| 2017-03-23 | Agalimmune (UK) | Bioline Rx (Israel) | $6 million and additional future payments based on development and commercial milestones | Cancer - Oncology |
